IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

CHI Advisors LLC

Q1 2023 Holdings

Filed 2023-05-11 | 24 holdings | $376.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Prometheus Biosciences IncCOM74349U108$100.3M934,13526.6%
Pliant Therapeutics Inc(PLRX)COM729139105$79.8M3,001,83521.2%
Vectivbio Hldg AGORD SHSH9060V101$44.7M5,255,48411.9%
Cullinan Oncology Inc(CGEM)COM230031106$34.3M3,349,4609.1%
Repare Therapeutics Inc(RPTX)COM760273102$29.5M2,997,9397.8%
Larimar Therapeutics Inc(LRMR)COM517125100$12.4M2,746,2653.3%
Keros Therapeutics Inc(KROS)COM492327101$11.1M261,0593.0%
Compass Therapeutics Inc(CMPX)COM20454B104$9.3M2,829,7122.5%
2Seventy BIO Inc(TSVT*)COMMON STOCK901384107$8.7M855,0002.3%
Inozyme Pharma IncCOM45790W108$7.7M1,342,1912.0%
Omega Therapeutics IncCOMMON STOCK68217N105$6.4M1,055,8821.7%
Ikena Oncology IncCOM45175G108$5.7M1,660,8721.5%
Rallybio CorpCOM75120L100$4.3M760,5431.2%
Orchard Therapeutics PLCSPON ADS NEW68570P200$4.2M785,7381.1%
Chinook Therapeutics Inc(290A)COM16961L106$3.1M135,0000.8%
Precision Biosciences IncCOM74019P108$2.6M3,469,8200.7%
Ovid Therapeutics Inc(OVID)COM690469101$2.2M864,8220.6%
Kezar Life Sciences IncCOM49372L100$2.2M689,4510.6%
Freeline Therapeutics HldgsSPONSORED ADS35655L107$2.2M4,729,4190.6%
Corvus Pharmaceuticals Inc(CRVS)COM221015100$2.1M2,339,4020.6%
Syros Pharmaceuticals Inc(SYRS)COM NEW87184Q206$2.0M767,4450.5%
Entrada Therapeutics Inc(TRDA)COM29384C108$817.4K56,3740.2%
Oncorus IncCOM68236R103$814.6K2,367,4360.2%
Prometheus Biosciences IncCallCOM74349U108$108.1K25,0000.0%